Abstract
A 53-year-old man complained of weight loss, night sweats, and splenomegaly. The patient was diagnosed with stage IV hepatosplenic γδ T-cell non-Hodgkin's lymphoma, a highly aggressive and rare form of peripheral T-cell lymphoma. After completing CHOP chemotherapy, the patient relapsed. He did not respond to subsequent alemtuzumab therapy.
Original language | English |
---|---|
Pages (from-to) | 241-243 |
Number of pages | 3 |
Journal | European journal of internal medicine |
Volume | 18 |
Issue number | 3 |
DOIs | |
Publication status | Published - 1 May 2007 |
Keywords
- Alemtuzumab
- Chemotherapy
- Hepatosplenic γδ T-cell lymphoma